このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

冷水への曝露が身体的および精神的健康に及ぼす影響

2026年9月26日 更新者:Laura Stewart、University of Northern Colorado

Cold-Water Immersion's Effects on Physical and Mental Health: A 4-Week Randomized Trial Comparing Cold Tub Versus Cold Shower

An interest in cold-water immersion (CWI) to elicit diverse physiological effects has been prevalent for centuries. CWI typically consists of bodily exposure to water at temperatures ranging from 5-10º C for various durations. CWI has profound cultural significance in different areas of the world, such as in Scandinavian countries, and has emerged as a popular modality for its purported health-promoting effects. Individuals on social media have repeatedly advocated for CWI as a method to improve muscular recovery, enhance sleep, and increase immune and cognitive function. Because of this, companies that specialize in cold tub production have become popularized; however, individuals who are seeking a more cost-effective option are drawn toward cold showers for their preferred method of cold exposure. Despite the scarcity of rigorous research investigating the difference in effects of cold tub versus cold shower CWI, individuals on social media promoting CWI via a shower continue to praise its comparable benefits to that of a tub. Therefore, investigations of chronic CWI (utilizing both a cold tub and a cold shower) is vital.

Thus, the purpose of the proposed study is to explore the varying effects of chronic CWI on neural and cognitive function using a cold tub and a cold shower. Further, the study aims to investigate performance measures and immune measures to create a comprehensive understanding of CWI's implications on human physiology over time. The investigators hypothesize measures relating to mental performance and health will improve after 4-weeks of CWI, and there will be no difference between tub and shower immersion groups.

調査の概要

研究の種類

介入

入学 (実際)

36

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Colorado
      • Greeley、Colorado、アメリカ、80639
        • University of Northern Colorado

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~45年 (大人)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Healthy volunteers
  • Aged 18-45

Exclusion Criteria:

  • Current holds a cold water exposure routine (≥3 sessions in the last month, consisting of ≥4 minutes per immersion)
  • Currently pregnant of planning to become pregnant
  • Chronic use of anti-inflammatory medication
  • Prior history of chronic disease conditions: Cardiovascular Disease, Diabetes, Cancer, Raynaud's Disease, or severe/untreated anxiety or depression

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:他の
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Cold Tub Immersion Group (CI)

Participants will utilize the research cold tub area (10 ºC, 4-minutes), following a standardized protocol (see intervention description).

Once thermoneutral procedures are complete, participants in the CI group will be seated in the cold tub and submerged into the water (10º C). The sternal notch of each participant will be used as the anatomical marker to mark submersion point. Participants will sit with both arms outstretched underwater with their backs not touching the sides of the tub. Participants with a shorter stature will be provided an underwater cushion to meet the submersion requirements. The 4-minute timer will begin once confirmation of the participants submersion level and posture is determined. Once completed, the participant will be instructed to slowly exit the tub and allowed to dry and change as necessary.

実験的:Cold Shower Group (CS)

Participants will utilize the research shower area (10 ºC, 4-minutes), following a standardized protocol (see intervention description).

Once thermoneutral procedures are complete, participants in the CS group will be instructed to enter the research shower area in Gunter 1610. Within the shower area, the walls of the shower will be numbered from 1 to 4, with 1 defined as facing the faucet, 2 defined as 90° to the right of side 1, 3 defined as 180° from the faucet, and 4 defined as 270° to the right or 90° C to the left from side 1. Participants will be instructed to turn 90° to the right cycling through sides 1 to 4 and then back to 1 every 15 seconds prompted by the researcher. This will allow the participant to complete three full rotations in the shower during the 4-minute intervention time. The shower faucet is modified and oriented in a way where it only produces cold water (10º C) when turned on. Once completed, the participant will be instructed to slowly exit the shower and is allowed to dry and change as necessary.

介入なし:Control Group (CO)

Participants will not participate in any cold water immersion.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Sustained Attention to Response Task (SART)
時間枠:Visit 1B (Week 1) and Visit 2B (Week 4)

The SART is a task used to evaluate sustained attention and inhibitory control. Participants will complete the SART task on a laboratory computer. The computerized test will display 225 randomly selected numbers ranging between 1 and 9; these numbers appear in different sizes throughout the duration of the test and are displayed in white on a black screen. Participants will be instructed to respond when each number appears by pressing the space bar on the computer's keyboard while refraining from pressing the space bar when the number 3 appears. Total error score will be calculated by assessing the number of space bar presses when no key should've been pressed as well as absent presses when a key should've been pressed.

Visit 1B (Week 1) and Visit 2B (Week 4)
Alternate Use Task (AUT)
時間枠:Visit 1B (Week 1) and Visit 2B (Week 4)

The Alternate Use Task is used to evaluate creativity and divergent thinking. The task will be derived from the original paper version of the AUT, in which an everyday object will be randomly selected and presented to the participant, and the participant will be tasked with thinking of a possible use for the presented object. Participants will be instructed to think of novel and unique uses that would deviate from traditional uses of the presented object. Participants will be given a blank sheet of paper and be granted 2-minutes to write down as many uses as possible. In this modified version of the original test, participants will be screened for originality, fluency, and flexibility.

Visit 1B (Week 1) and Visit 2B (Week 4)
Piper Fatigue Scale (PFS)
時間枠:Visit 1B (Week 1) and Visit 2B (Week 4)

Participants will be asked to complete the Piper Fatigue Scale (PFS), a 27-question questionnaire that utilizes a Likert scale (1-10) to assess subdomains of behavioral, affective, sensory, and cognitive/mood attributes of fatigue. This version of the PFS is a subjective measure of fatigue using a 10-point Likert scale ranging from 0 - 10 with 0 indicating "No Distress" and 10 indicating "A Great Deal", "Mild" to "Severe", "Pleasant" to "Unpleasant", "Agreeable" to "Disagreeable", "Protective" to "Destructive", "Positive" to "Negative", "Normal" to "Abnormal", "Strong" to "Weak", "Awake" to "Sleepy", "Lively" to "Listless", "Refreshed" to "Tired", "Energetic" to "Unenergetic", "Patient" to "Impatient", "Relaxed" to "A Great Deal", "Exhilarated" to "Depressed", "Able to Concentrate" to "Unable to Concentrate", "Able to Remember" to "Unable to Remember", and "Able to Think Clearly" to "Unable to Think Clearly".

Visit 1B (Week 1) and Visit 2B (Week 4)
Perceived Stress Scale (PSS)
時間枠:Visit 1B (Week 1) and Visit 2B (Week 4)

Participants will be asked to complete the Perceived Stress Scale (PSS), a classic stress assessment tool used to gauge how different situations affect feelings and perceived stress. This version of the PSS is a subjective measure of stress using a 5-point Likert scale ranging from 0 - 4 with 0 indicating "Never", 1 indicating "Almost Never", 2 indicating "Sometimes", 3 indicating "Fairly Often", and 4 indicating "Very Often".

Visit 1B (Week 1) and Visit 2B (Week 4)
Mindful Attention Awareness Scale (MAAS)
時間枠:Visit 1B (Week 1) and Visit 2B (Week 4)

Participants will be asked to complete the Mindful Attention Awareness Scale (MAAS), a 15-item scale designed to assess the core characteristics of mindfulness. This version of the MAAS is a subjective measure of mindfulness using a 6-point Likert scale ranging from 1 - 6 with 1 indicating "Almost Always", 2 indicating "Very Frequently", 3 indicating "Somewhat Frequently", 4 indicating "Somewhat Infrequently", 5 indicating "Very Infrequently", and 6 indicating "Almost Never".

Visit 1B (Week 1) and Visit 2B (Week 4)
Heart Rate Variability (HRV)
時間枠:Visit 1B (Week 1) and Visit 2B (Week 4)

Heart rate variability (HRV) will be analyzed to determine the fluctuation in the time intervals between adjacent heartbeats to assess autonomic regulation of the heart. Resting HR and HRV were measured using the electrocardiograph (GE CASE Exercise Testing System Version 6.0, Chicago, Illinois). To measure HRV, the root mean square successive difference method (RMSSD) was used with the 10-second electrocardiogram reading. Based on the outcome of this assessment, participants with SDNN values below 50 ms will be classified as unhealthy, 50-100 ms will be classified as having compromised health, and above 100 ms will be classified as healthy.

Visit 1B (Week 1) and Visit 2B (Week 4)
Pittsburgh Sleep Quality Index (PSQI)
時間枠:Visit 1A (Week 1) and Visit 2A (Week 4)

Participants will be asked to complete the Pittsburgh Sleep Quality Index (PSQI). The PSQI is a 19-question self-reported sleep quality screening tool broken up into 7 subcategories for scoring, such as subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction.

Visit 1A (Week 1) and Visit 2A (Week 4)
Serum Analysis - Brain-Derived Neurotrophic Factor (BDNF)
時間枠:Visit 1A (Week 1) and Visit 2A (Week 4)

Approximately 40mL of whole blood will be collected into serum separator tubes (Beckton Dickinson, East Rutherford, NJ, USA), allowed to clot for 30-minutes at room temperature, then centrifuged at 2000 RPM for 15 min. The serum will be pipetted into 1.5 mL microcentrifuge tubes (Eppendorf AG, Hamburg, Germany) and immediately stored in a -80 °C freezer. Serum concentrations of BDNF (Sigma-Aldrich, St. Louis, MO, USA) will be determined with a commercially available enzyme-linked immunosorbent assays. Microplates will be read with an ELx800 BioTek microplate reader (BioTek Instruments, Inc., Winooski, VT, USA) at the recommended wavelength of 450 nanometers.

Visit 1A (Week 1) and Visit 2A (Week 4)

二次結果の測定

結果測定
メジャーの説明
時間枠
Anthropometric Measures - Height
時間枠:Visit 1A (Week 1) and Visit 2A (Week 4)

Height will be obtained in centimeters (cm)( using a stadiometer SECA 220 (Chino, California, USA).

Visit 1A (Week 1) and Visit 2A (Week 4)
Anthropometric Measures - Weight
時間枠:Visit 1A (Week 1) and Visit 2A (Week 4)

Weight will be obtained in kilograms (kg) using a Detecto standing digital scale (Webb City, Missouri, USA).

Visit 1A (Week 1) and Visit 2A (Week 4)
Anthropometric Measures - Lean Body Mass
時間枠:Visit 1A (Week 1) and Visit 2A (Week 4)

Lean body mass (LBM) will be measured in kilograms and evaluated using air displacement plethysmography using a calibrated BOD POD (COSMED USA Inc., Concord, CA).

Visit 1A (Week 1) and Visit 2A (Week 4)
Anthropometric Measures - Body Fat Percentage
時間枠:Visit 1A (Week 1) and Visit 2A (Week 4)

Body fat percentage (BF%) will be measured as a percentage of estimated body fat relative to total body mass and evaluated using air displacement plethysmography using a calibrated BOD POD (COSMED USA Inc., Concord, CA).

Visit 1A (Week 1) and Visit 2A (Week 4)
Hydration
時間枠:Visit 1A (Week 1) and Visit 2A (Week 4)

A refractometer (Atago, Tokyo, JPN) will be used to evaluate urine specific gravity with a dehydration cutoff point set to ≥1.020 mg/dL. Dehydrated participants will be given time to hydrate. If dehydration persisted, participants will be asked to reschedule the session. After verbal compliance and hydration status are confirmed, participants will proceed with the study's procedures.

Visit 1A (Week 1) and Visit 2A (Week 4)
Qualitative Assessment
時間枠:Visit 1A (Week 1) and Visit 2A (Week 4)

Participants will be asked to complete a qualitative questionnaire to indicate their perceptions of cold water therapy. The purpose of this assessment is to see if participants' perceptions change throughout the study. Further, this questionnaire allows participants to provide any extra qualitative feedback to gain a comprehensive insight on their chronic CWI experience. No scale is used in this survey; however, participants are given the opportunity to report their perceptions of cold immersion using the following choices: increases energy, reduces anxiety, improves sleep, improves mental health, improves physical health, improves immune system, reduces soreness or pain, or other [text response].

Visit 1A (Week 1) and Visit 2A (Week 4)
Visual Analogue Scale (VAS) of Discomfort
時間枠:Every water immersion visit (days 1-12; 3 days per week for 4 weeks)

Participants will be assessed on their subjective ratings of discomfort as they acclimate to the cold exposure. During cold-water immersion visits (at the 1-minute mark of immersion, participants will be presented with the Visual Analogue Scale (VAS) of Discomfort, a modified version of a 0-10 item pain scale. This version of the VAS is a subjective measure of discomfort using a 11-point Likert scale ranging from 0 - 10 with 0 indicating "No Discomfort" and 10 indicating "Maximal Discomfort." Because there are twelve total water immersion visits (four weeks, three days per week), the VAS is used twelve times in total.

Every water immersion visit (days 1-12; 3 days per week for 4 weeks)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年10月10日

一次修了 (実際)

2025年12月1日

研究の完了 (実際)

2025年12月1日

試験登録日

最初に提出

2024年10月10日

QC基準を満たした最初の提出物

2024年10月29日

最初の投稿 (実際)

2024年10月31日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月30日

QC基準を満たした最後の更新が送信されました

2026年9月26日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 2404058903

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

We will make all study documents available by reasonable request (Laura.stewart@unco.edu) up to 3 years after data collection is complete.

IPD 共有時間枠

Start: Oct 1, 2025 - Oct 1, 2028

IPD 共有アクセス基準

Anyone who contacts Laura.stewart@unco.edu with a reasonable request.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する